Skip to main content

Vitamin D Deficiency

9
Pipeline Programs
15
Companies
10
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
5
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

10 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
AliskirenPhase 41 trial
Active Trials
NCT00974922Terminated40Est. Dec 2011
MSD
MSDIreland - Ballydine
3 programs
1
2
cholecalciferolPhase 3
cholecalciferolPhase 3
MK0822APhase 2
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
3 programs
1
2
cholecalciferolPhase 3
cholecalciferolPhase 3
MK0822APhase 2
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
1
cholecalciferolPhase 31 trial
Active Trials
NCT00292591Completed501Est. Jan 2010
Pfizer
PfizerNEW YORK, NY
2 programs
1
cholecalciferolPhase 11 trial
cholecalciferolN/A1 trial
Active Trials
NCT01508845Completed61Est. Jun 2013
NCT01268176Completed62Est. Jun 2012
Merck & Co.
Merck & Co.RAHWAY, NJ
2 programs
MK0822APHASE_21 trial
cholecalciferolPHASE_31 trial
Active Trials
NCT00242476Completed216Est. Jul 2006
NCT00681590Completed105Est. Apr 2009
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Redoxon VIN/A1 trial
Active Trials
NCT02876315Completed42Est. Dec 2019
Abiogen
AbiogenItaly - Pisa
1 program
Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation N/A1 trial
Active Trials
NCT06452082Completed200Est. Sep 2025
Martin Pharmaceuticals
1 program
cholecalciferolN/A1 trial
Active Trials
NCT01503216Completed120Est. May 2012
Faes Farma
Faes FarmaSpain - Leioa
1 program
Calcifediol 75mcgPHASE_2_31 trial
Active Trials
NCT04735926Completed674Est. Apr 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SandozAliskiren
Merck & Co.cholecalciferol
Human BioSciencescholecalciferol
Faes FarmaCalcifediol 75mcg
Merck & Co.MK0822A
Pfizercholecalciferol
AbiogenRisk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation
Oregon TherapeuticsRedoxon VI
Martin Pharmaceuticalscholecalciferol
Pfizercholecalciferol

Clinical Trials (10)

Total enrollment: 2,021 patients across 10 trials

Vitamin D Deficiency in Patients With Hypertension

Start: Aug 2009Est. completion: Dec 201140 patients
Phase 4Terminated
NCT00681590Merck & Co.cholecalciferol

Safety of Vitamin D Supplementation in Older Persons

Start: Apr 2008Est. completion: Apr 2009105 patients
Phase 3Completed

Evaluation of Vitamin D Requirements During Pregnancy

Start: Jan 2004Est. completion: Jan 2010501 patients
Phase 3Completed
NCT04735926Faes FarmaCalcifediol 75mcg

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency

Start: Dec 2020Est. completion: Apr 2023674 patients
Phase 2/3Completed

A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)

Start: Sep 2005Est. completion: Jul 2006216 patients
Phase 2Completed
NCT01268176Pfizercholecalciferol

The Effect of a Meal on Vitamin D Absorption

Start: Dec 2010Est. completion: Jun 201262 patients
Phase 1Completed
NCT06452082AbiogenRisk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation

Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl

Start: Mar 2024Est. completion: Sep 2025200 patients
N/ACompleted

The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults

Start: Dec 2016Est. completion: Dec 201942 patients
N/ACompleted

Safety and Bioefficacy of Vitamin D2 and Vitamin D3

Start: Jan 2012Est. completion: May 2012120 patients
N/ACompleted
NCT01508845Pfizercholecalciferol

A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption

Start: Jan 2012Est. completion: Jun 201361 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 late-stage (Phase 3) programs, potential near-term approvals
15 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.